DOLASTATIN-10 DERIVATIVE, METHOD OF PRODUCING THE SAME AND ANTICANCER DRUG COMPOSITION CONTAINING THE SAME
申请人:CELLTRION, INC.
公开号:US20150225455A1
公开(公告)日:2015-08-13
The present invention provides a dolastatin-10 derivative having excellent anticancer activity, a method of producing the same and anticancer drug composition containing the same as an active ingredient.
本发明提供了一种具有优异的抗癌活性的多拉斯他汀-10衍生物,以及其制备方法和包含其作为活性成分的抗癌药物组合物。